POLE p.Pro338=
c.1014C>T · rs143102561 · VCV383198
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -5.7 | GERP -3.4 |
| Overall | ||
| CADD | 0.185 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.118% | 846 |
| European (non-Finnish) | 0.000599% | 167,008 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- POLE
- Protein
- p.Pro338=
- Coding
- c.1014C>T
- MANE Select
- NM_006231
- dbSNP
- rs143102561
- Type
- single nucleotide variant
- Location
- chr12:132676100 (GRCh38)
- Gene constraint
- LOEUF 0.75 · pLI <0.01 · ClinGen HI 1/3 (gnomAD)
- Structure
- AlphaFold pLDDT 80.32 · 18 PDB
Disease context
intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: colorectal cancer, susceptibility to, 12facial dysmorphism-immunodeficiency-livedo-short stature syndromehereditary neoplastic syndrome
Similar variants
- POLE p.Pro338Leu Conflicting classifications of pathogenicity ★ ⚠ same residue
- POLE p.Pro338Ala Uncertain significance ★ ⚠ same residue
- POLE p.Pro338Ser Uncertain significance ★ ⚠ same residue
- POLE p.Pro338Thr Uncertain significance ★ ⚠ same residue
- POLE c.1686+32C>G Pathogenic/Likely pathogenic ★★ same condition
- POLE c.5678+1G>T Pathogenic ★★ same condition
- POLE p.Leu424Val Pathogenic ★★ same condition
- POLE c.1020+5G>A Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pole-p-pro338 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown